High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients

被引：118
|
作者：
Pisani, A [1 ]
Fezza, F
Galati, S
Battista, N
Napolitano, S
Finazzi-Agró, A
Bernardi, G
Brusa, L
Pierantozzi, M
Stanzione, P
Maccarrone, M
机构：
[1] Univ Roma Tor Vergata, Neurol Clin, Dept Neurosci, Rome, Italy
[2] IRCCS, Santa Lucia Fdn, Rome, Italy
[3] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy
[4] Univ Teramo, Dept Biochem Sci, Rome, Italy
[5] IRCCS, Ctr Expt Neurobiol C Mondino, Rome, Italy
来源：
ANNALS OF NEUROLOGY | 2005年 / 57卷 / 05期
关键词：
D O I：
10.1002/ana.20462
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：777 / 779
页数：3
相关论文
共 50 条
  • [31] Study of Urokinase receptor in cerebrospinal fluid in patients with Parkinson's disease
    Thomas, M.
    MOVEMENT DISORDERS, 2006, 21 : S514 - S514
  • [32] Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease
    Navarro, JA
    Molina, JA
    JimenezJimenez, FJ
    BenitoLeon, J
    OrtiPareja, M
    Gasalla, T
    CabreraValdivia, F
    Vargas, C
    deBustos, F
    Arenas, J
    ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 (06): : 411 - 414
  • [33] Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease
    J. A. Molina
    F. J. Jiménez-Jiménez
    A. Hernánz
    E. Fernández-Vivancos
    S. Medina
    F. de Bustos
    C. Gómez-Escalonilla
    Y. Sayed
    Journal of Neural Transmission, 2002, 109 : 1035 - 1044
  • [34] Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease
    JimenezJimenez, FJ
    Molina, JA
    Vargas, C
    Gomez, P
    Navarro, JA
    BenitoLeon, J
    OrtiPareja, M
    Gasalla, T
    Cisneros, E
    Arenas, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 141 (1-2) : 39 - 44
  • [35] Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease
    Meseguer, I
    Molina, JA
    Jiménez-Jiménez, FJ
    Aguilar, MV
    Mateos-Vega, CJ
    González-Muñoz, MJ
    de Bustos, F
    Ortí-Pareja, M
    Zurdo, M
    Berbel, A
    Barrios, E
    Martínez-Para, MC
    JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (3-4) : 309 - 315
  • [36] Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease
    Rubio, JC
    de Bustos, F
    Molina, JA
    Jiménez-Jiménez, FJ
    Benito-León, J
    Martín, MA
    Campos, Y
    Ortí-Pareja, M
    Cabrera-Valdivia, F
    Arenas, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 155 (02) : 192 - 195
  • [37] Cerebrospinal Fluid β-Glucocerebrosidase Activity Is Reduced in Parkinson's Disease Patients
    Parnetti, Lucilla
    Paciotti, Silvia
    Eusebi, Paolo
    Dardis, Andrea
    Zampieri, Stefania
    Chiasserini, Davide
    Tasegian, Anna
    Tambasco, Nicola
    Bembi, Bruno
    Calabresi, Paolo
    Beccari, Tommaso
    MOVEMENT DISORDERS, 2017, 32 (10) : 1423 - 1431
  • [38] Abnormal subpopulations of monocytes in the cerebrospinal fluid of patients with Parkinson's disease
    Pillny, Christiane
    Nitsch, Louisa
    Proske-Schmitz, Sabine
    Sharma, Amit
    Wuellner, Ullrich
    PARKINSONISM & RELATED DISORDERS, 2021, 84 : 144 - 145
  • [39] Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
    Schroeder, Jens B.
    Pawlowski, Matthias
    zu Hoerste, Gerd Meyer
    Gross, Catharina C.
    Wiendl, Heinz
    Meuth, Sven G.
    Ruck, Tobias
    Warnecke, Tobias
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [40] Selenium speciation analysis in the cerebrospinal fluid of patients with Parkinson's disease
    Maass, Fabian
    Michalke, Bernhard
    Willkommen, Desiree
    Schulte, Claudia
    Toenges, Lars
    Boerger, Matthias
    Zerr, Inga
    Baehr, Mathias
    Lingor, Paul
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2020, 57 : 110 - 115
12345